Elevance Health forward PE ELV
Share price divided by analysts' consensus earnings for the next twelve months, since 2001.
- Today, Oct 23, 2026
- 16.1×
- 10-year median
- 14.8×
- Against its 10-year history
- 80th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 8.8× to 19.5×
- Peer median
- 15.0×
Elevance Health's forward PE is 16.1× as of Oct 23, 2026.
That is above its ten-year median of 14.8×, higher than on 80% of days in the last ten years.
Over that time it ranged from 8.8× in Mar 2020 to 19.5× in Jan 2018.
The median for 6 health insurers of a similar size is 15.0×.
Forward PE over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 16.1× | 11.8× | 16.3× |
| 2025 | 14.1× | 11.0× | 15.5× |
| 2024 | 12.7× | 12.5× | 16.4× |
| 2023 | 13.2× | 12.3× | 15.4× |
| 2022 | 16.2× | 14.9× | 18.7× |
| 2021 | 16.7× | 12.0× | 16.7× |
| 2020 | 14.8× | 8.8× | 16.0× |
| 2019 | 13.2× | 9.9× | 16.5× |
| 2018 | 15.0× | 14.3× | 19.5× |
| 2017 | 17.0× | 13.6× | 17.7× |
| 2016 | 13.6× | 11.1× | 14.4× |
| 2015 | 13.9× | 13.0× | 20.2× |
| 2014 | 15.3× | 10.7× | 15.5× |
| 2013 | 13.0× | 8.6× | 13.9× |
| 2012 | 8.7× | 7.9× | 10.9× |
| 2011 | 9.3× | 8.1× | 11.9× |
| 2010 | 8.9× | 8.1× | 13.0× |
| 2009 | 11.4× | 6.5× | 11.6× |
| 2008 | 7.6× | 5.6× | 16.0× |
| 2007 | 16.1× | 13.4× | 16.3× |
Against its peers
Companies in Medical - Healthcare Plans nearest Elevance Health's size, closest first, today.
| Company | Forward PE |
|---|---|
| ELVElevance Health | 16.1× |
| CICigna | 9.7× |
| CVSCVS Health | 11.5× |
| HUMHumana | 33.7× |
| CNCCentene | 15.0× |
| UNHUnitedHealth | 18.5× |
| OSCROscar Health | n/m |
| Peer median | 15.0× |
Where Elevance Health ranks
What the forward PE tells you
Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.
Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.
More on Elevance Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.